8718 Federal Register / Vol. 90, No. 20 / Friday, January 31, 2025 / Notices 

Melbourne, FL; FlexCompute Inc., 

Watertown, MA; MPI America Inc., San 

Jose, CA; Phlotonics, Inc., Rochester, 

NY; PICadvanced US LLC, Fort 

Lauderdale, FL; and Research 

Foundation on behalf of the University 

at Albany, Albany, NY, have been added 

as parties to this venture. 

Also, AAYUNA Inc., Allentown, PA; 

Trustees of Boston University, Boston, 

MA; Ebara Technologies, Inc., 

Sacramento, CA; George Washington 

University, Washington, DC; Presco 

Engineering, Woodbridge, CT; Teledyne 

Princeton Instruments, Trenton, NJ; and 

Milkshake Technology Inc., Menlo Park, 

CA, have withdrawn as parties to this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and AIM 

Photonics intends to file additional 

written notifications disclosing all 

changes in membership. 

On June 16, 2016, AIM Photonics 

filed its original notification pursuant to 

section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to section 

6(b) of the Act on July 25, 2016 (81 FR 

48450). 

The last notification was filed with 

the Department on July 1, 2024. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on September 26, 2024 (89 FR 

78903). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2025–02044 Filed 1–30–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1481] 

Bulk Manufacturer of Controlled 

Substances Application: Organic 

Consultants LLC DBA Cascade 

Chemistry 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Organic Consultants LLC DBA 

Cascade Chemistry has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before April 1, 2025. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 1, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 26, 2024, 

Organic Consultants LLC DBA Cascade 

Chemistry, 90 North Polk Street, Suite 

200, Eugene, Oregon 97402–4109 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

Amphetamine ................................................................................................................................................................... 1100 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Codeine ........................................................................................................................................................................... 9050 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-A .............................................................................................................................................. 9232 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Meperidine intermediate-C .............................................................................................................................................. 9234 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

The company plans to bulk 

manufacture small quantities of the 

listed controlled substances for internal 

use or for sale as analytical reference 

standard materials to its customers. No 

other activities for these drug codes are 

authorized for this registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2025–02008 Filed 1–30–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1483] 

Importer of Controlled Substances 

Application: Medi-Physics Inc. DBA GE 

Healthcare 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Medi-Physics Inc. DBA GE 

Healthcare has applied to be registered 

as an importer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 3, 2025. Such 


ddrumheller on DSK120RN23PROD with NOTICES1